Gastroenterology medical billing services
One procedure that changes its billing identity mid-way through, frequency rules that vary by risk category, and pathology that is often billed by someone else.
Also called: GI · Digestive Health. We keep one page per specialty rather than a page per name.
Why gastroenterology billing is different
Gastroenterology has a coding problem no other specialty has in quite the same form: a screening colonoscopy that finds and removes a polyp becomes a therapeutic procedure while the patient is still on the table. The clinical event is one procedure. The billing event is two different things depending on what happened, and the difference determines whether the patient owes cost-sharing.
Get it wrong in one direction and the patient is billed hundreds of dollars for a preventive service they were told was free. Get it wrong in the other and the practice waives revenue it was entitled to. Commercial plans and Medicare handle this conversion differently — modifier 33 for one, modifier PT for the other — and the front desk usually finds out weeks later from an angry phone call.
Frequency is the second layer. Screening intervals differ by risk category and by payer, and a colonoscopy performed a month inside the interval is denied outright. Third, pathology on the specimens is a separate claim with its own component split, and practices that use an outside lab need to know exactly which part of it, if any, they may bill.
Codes we work with
The families this specialty actually bills, and where each one carries a rule worth knowing.
| Family | Range | Notes |
|---|---|---|
| Colonoscopy | 45378–45398 | Diagnostic and therapeutic, by technique of lesion removal |
| Medicare screening colonoscopy | G0105, G0121 | High risk and not high risk |
| Upper endoscopy | 43235–43259 | Diagnostic, biopsy, dilation and ablation |
| Flexible sigmoidoscopy | 45330–45350, G0104 | Commercial and Medicare screening equivalents |
| Capsule endoscopy | 91110, 91111 | Requires authorisation with most payers |
| Motility and function studies | 91010–91299 | Manometry, pH monitoring, breath testing |
| Moderate sedation | 99152–99153, G0500 | Only where not included in the base procedure |
| Pathology | 88304, 88305, 88312–88342 | Component split where the specimen is read externally |
| Fecal and stool testing | 82274, 81528 | Screening frequency rules apply |
Modifiers that matter
And the specific way each one is most often misused in this specialty.
| Modifier | Use | Common error |
|---|---|---|
| 33 | Preventive service — commercial plans | Omitted when a screening becomes diagnostic, so the patient is charged cost-share |
| PT | Screening converted to a diagnostic or therapeutic procedure — Medicare | Confused with modifier 33 and applied to the wrong payer type |
| 53 | Discontinued procedure | Not used when an incomplete colonoscopy is abandoned, so the whole claim is denied |
| 52 | Reduced services | Used where 53 is correct, or vice versa |
| 59 / XU | Distinct procedural service | Applied between endoscopy codes within the same family that bundle by design |
| 26 / TC | Pathology component split | Global billing where the specimen was read by an outside laboratory |
Top denial reasons
With the CARC code you will see on the remittance, and what we do to stop each one recurring.
| Denial | CARC | How we prevent it |
|---|---|---|
| Screening frequency not met | CO-119, CO-96 | Last screening date and risk category confirmed at eligibility verification |
| Screening-to-diagnostic conversion not indicated | CO-4, CO-16 | Modifier 33 or PT applied per payer type from the operative findings |
| Diagnosis does not support the procedure | CO-50 | Indication mapped to payer coverage policy before scheduling |
| Procedure component bundled | CO-97 | Endoscopy family bundling applied instead of a reflex modifier 59 |
| Capsule study or motility test not authorised | CO-197 | Authorisation determined and obtained before the study |
Prior authorisation in this specialty
Diagnostic colonoscopy, capsule endoscopy, motility studies and most biologic therapy require authorisation with commercial payers, and several plans now require it for surveillance colonoscopy performed inside the standard interval. Screening performed at the recommended interval usually does not — which is precisely why the screening-versus-diagnostic distinction has to be settled before the patient is scheduled rather than after the pathology returns. We determine the requirement per payer and indication, and record the authorisation against the claim so it survives the conversion.
Where revenue leaks
- Patients billed cost-share on a converted screening, generating refunds and complaints instead of collections
- Incomplete procedures written off entirely instead of billed with modifier 53
- Pathology component revenue lost by billing globally when only the professional component is payable
- Surveillance procedures performed inside a frequency limit nobody checked
What we do for gastroenterology practices
The parts of the cycle where this specialty gains the most, framed for how it actually bills.
Eligibility & Benefits Verification
Coverage and benefits confirmed before the visit, not after the denial.
See eligibility verificationPrior Authorization Services
Auth requests submitted, tracked, and escalated so procedures aren't delayed.
See prior authorizationDenial Management & Appeals
Root-cause analysis, corrected claims, and clinical appeals filed inside payer deadlines.
See denial managementPatient Billing & Collections
Statements, payment plans, and patient support that doesn't damage the relationship.
See patient billingSee what this specialty is losing in your practice
We run the analysis against gastroenterology benchmarks, not a generic template. Send 90 days of claims data and keep the report either way.
Questions about gastroenterology billing
How do you handle a screening that becomes diagnostic?
Modifier 33 for commercial plans, modifier PT for Medicare, applied from the operative findings — so the patient is not billed cost-share incorrectly.
Do you check screening frequency before the procedure?
Yes. The last screening date and risk category are confirmed during eligibility verification.
What happens when a colonoscopy is incomplete?
It is billed with modifier 53 rather than written off, where the documentation supports a discontinued procedure.
Can you bill our pathology?
Yes, with the correct component split depending on whether the specimen is read in-house or by an outside laboratory.
Adjacent specialties
Specialties whose billing shares rules, payers or authorisation patterns with this one.